Digestive Diseases and Sciences

, Volume 63, Issue 11, pp 2889–2897 | Cite as

Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients

  • Marisa Claudia Alvarez
  • Julien Fernandes
  • Valérie Michel
  • Eliette Touati
  • Marcelo Lima RibeiroEmail author
Original Article



GATA factors, which constitute a family of transcription regulatory proteins, participate in gastrointestinal development. Trefoil factor 1 (TFF1) plays a crucial role in mucosal defense and healing, and evidence suggests that GATA-5 mediated its regulation. Gastric cancer is a multiple-step process triggered by Helicobacter pylori and is characterized by accumulation of molecular and epigenetic alteration. The aim of this study was to evaluate the effect of H. pylori infection on the regulation of GATA-5 and TFF1 in vitro and in vivo.


Infected cells exhibited upregulation of GATA-5 and TFF1 after 48 h. An increase in GATA-5 and TFF1 mRNA levels was also found in mice samples after 6 and 12 months of infection, respectively. In human samples, we found an association between H. pylori infection and GATA-5 upregulation. In fact, among H. pylori-infected patients, hypermethylation was observed in 45.5% of pediatric samples, in 62.6% of chronic gastritis samples, and in 63% of gastric cancer samples. Regarding TFF1, the expression levels were similar in pediatrics and adults patients, and were independent of H. pylori infection, and the expression of these factors was downregulated in gastric cancer samples. GATA-5 promoter methylation was associated with a decrease in TFF1 mRNA levels.


Our results suggest that the upregulation of GATA-5 and TFF1 observed in vitro and in vivo may be correlated with a protective effect of the mucosa in response to infection. The epigenetic inactivation of GATA-5 observed in human biopsies from infected patients may suggest that this alteration is an early event occurring in association with H. pylori infection.


H. pylori GATA-5 TFF1 DNA methylation 



We thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/02678-6 and 2011/11224-1) and CNPq for providing financial support.

Author’s contributions

MCA participated in the design of the study, carried out the bacteria culture, cells culture and co-culture, DNA methylation assay, expression analysis, statistical analysis, and wrote the manuscript. JF participated in cells culture, co-culture, and expression analysis; VM participated in animal infection and RNA extraction; ET and MLR conceived the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.


  1. 1.
    Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin N Am. 1993;22:169–182.Google Scholar
  2. 2.
    Drumm B, Day AS, Gold B, et al. Helicobacter pylori and peptic ulcer. Working group report of the second world congress of pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2004;39:S626–S631.CrossRefGoogle Scholar
  3. 3.
    Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res. 2011;1:9–17.CrossRefGoogle Scholar
  4. 4.
    Ding SZ, Goldberg JB, Hatekeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetics mechanism in gastric carcinogenesis. Future Oncol. 2010;6:851–862.CrossRefGoogle Scholar
  5. 5.
    Roa JCS, García P, Melo A, et al. Gene methylation patterns in digestive tumors. Rev Méd Chile. 2008;136:451–458.Google Scholar
  6. 6.
    Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427–5440.CrossRefGoogle Scholar
  7. 7.
    Esteller M. CpG island methylation and histone modifications: biology and significance. ErnstSchering Res Found Workshop. 2006;57:115–126.CrossRefGoogle Scholar
  8. 8.
    Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847–2851.PubMedGoogle Scholar
  9. 9.
    Waki T, Tamura G, Tsuchiya T, et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol. 2002;161:399–403.CrossRefGoogle Scholar
  10. 10.
    Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52:502–506.CrossRefGoogle Scholar
  11. 11.
    Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12:989–995.CrossRefGoogle Scholar
  12. 12.
    Nakajima T, Yamashita S, Maekita T, et al. The presence of a methylation fingerprint of Helicobacter infection in human gastric mucosae. Int J Cancer. 2009;124:905–910.CrossRefGoogle Scholar
  13. 13.
    Bussière F, Michel V, Mémet S, et al. H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression. Cell Microbiol. 2010;12:1124–1133.CrossRefGoogle Scholar
  14. 14.
    Alvarez MC, Santos JC, Maniezzo N, et al. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol. 2013;19:3043–3051.CrossRefGoogle Scholar
  15. 15.
    Alvarez MC, Ladeira MS, Scaletsky IC, Pedrazzoli J Jr, Ribeiro ML. Methylation pattern of THBS1, GATA-4, and HIC1 in pediatric and adult patients infected with Helicobacter pylori. Dig Dis Sci. 2013;58:2850–2857. Scholar
  16. 16.
    Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer. 2010;12:1178–1188.CrossRefGoogle Scholar
  17. 17.
    Laverriere A, MacNeill C, Mueller C, et al. GATA-4/5/6, a subfamily of three transcription factors transcribed in the developing heart and gut. J Biol Chem. 1994;269:23177–23184.Google Scholar
  18. 18.
    Wen X, Akiyama Y, Pan KF, et al. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol. 2010;16:1201–1208.CrossRefGoogle Scholar
  19. 19.
    Akiyama Y, Watkins N, Suzuki H, et al. GATA-4 and GATA-5 transcription factor genes and potential dowstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 2003;23:8429–8439.CrossRefGoogle Scholar
  20. 20.
    Guo M, Akiyama Y, House MG, et al. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res. 2004;10:7917–7924.CrossRefGoogle Scholar
  21. 21.
    Guo M, House MG, Akiyama Y, et al. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006;119:2078–2083.CrossRefGoogle Scholar
  22. 22.
    Wu MS, Shun CT, Wang HP, et al. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. J Cancer Res. 1998;89:278–282.Google Scholar
  23. 23.
    Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408–1419.CrossRefGoogle Scholar
  24. 24.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−∆∆(CT)) method. Methods. 2001;25:402–408.CrossRefGoogle Scholar
  25. 25.
    Jones PA, Baylin SB. The fundamental role of epigenetics events in cancer. Nat Rev Genet. 2002;3:415–428.CrossRefGoogle Scholar
  26. 26.
    Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 1996;274:259–262.CrossRefGoogle Scholar
  27. 27.
    Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265.CrossRefGoogle Scholar
  28. 28.
    Lassus H, Laitinen MP, Anttonen M, et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab Invest. 2001;81:517–526.CrossRefGoogle Scholar
  29. 29.
    Rio MC, Chenard MP, Wolf C, et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 1991;100:375–379.CrossRefGoogle Scholar
  30. 30.
    Baylin S, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–116.CrossRefGoogle Scholar
  31. 31.
    Nardone G, Compare D. Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:243–248.CrossRefGoogle Scholar
  32. 32.
    Nan HM, Song YJ, Yun HY, et al. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol. 2005;25:3834–3841.CrossRefGoogle Scholar
  33. 33.
    Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;8:599–612.CrossRefGoogle Scholar
  34. 34.
    Tahara T, Hibata T, Nakamura M, et al. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa. Int J Mol Med. 2009;24:563–569.CrossRefGoogle Scholar
  35. 35.
    Gao X, Sedgwick T, Shi YB, et al. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol. 1998;18:2901–2911.CrossRefGoogle Scholar
  36. 36.
    Soutto M, Belkhiri A, Piazuelo MB, et al. Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest. 2011;121:1753–1767.CrossRefGoogle Scholar
  37. 37.
    Soutto M, Chen Z, Katsha AM, et al. Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Cancer. 2015;121:4348–4358.CrossRefGoogle Scholar
  38. 38.
    Sobota RS, Kodaman N, Mera R, et al. Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Hum Genet. 2016;135:895–906.CrossRefGoogle Scholar
  39. 39.
    McClain M, Shaffer CL, Israel DA, et al. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genom. 2009;10:3.CrossRefGoogle Scholar
  40. 40.
    Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174.CrossRefGoogle Scholar
  41. 41.
    Lee A, Rourke J, De Ungria MC, Robertson B, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112:1386–1397.CrossRefGoogle Scholar
  42. 42.
    Vivas JR, Regnault B, Michel V, et al. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol. 2008;21:515–526.CrossRefGoogle Scholar
  43. 43.
    Dixon M, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.CrossRefGoogle Scholar
  44. 44.
    Coelho LGV, Barros CA, Lima DCA. National consensus on ‘‘H. pylori’’. GED. 1996;15:53–58.Google Scholar
  45. 45.
    Mikula M, Dzwonek A, Jagusztyn-Krynicka K, et al. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Methods. 2003;55:351–359.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Programa de Pos Graduacao em Ciencias da SaudeUniversidade São FranciscoBragança PaulistaBrazil
  2. 2.Programa de Pós Graduação em Genética e Biologia MolecularUNICAMPCampinasBrazil
  3. 3.Unité de Pathogenése de HelicobacterInstitut PasteurParisFrance

Personalised recommendations